Persistence pays out exercise benefits in heart failureNews-Medical.netBy Eleanor McDermid, Senior medwireNews Reporter. Health benefits derived from regular exercise accumulate over the long term, shows a 10-year study in patients with heart failure (…
Report: Ohio nurse didn't realize she discarded kidney
A nurse who accidentally disposed of a living donor's kidney during a transplant said she didn't realize it was in chilled, protective slush that she removed from an operating room, took down a hall to a dirty utility room and "flushed dow…
Seattle Genetics and Millennium Complete Enrollment in Phase III AETHERA Trial of ADCETRIS® for Post-Transplant …
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , today announced the completion of patient enrollment in a phase III clinical trial of ADCETRIS for post-transplant …
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release … – Sacramento Bee
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release …Sacramento BeeDeveloped by Astellas, tacrolimus extended release capsules are a once daily formulation of calcineurin-inhibitor immunosuppressant tacrolimus. The NDA submissi…
Barfi's success is humbling; response was unexpected: Basu – Moneycontrol.com
IBTimes IndiaBarfi's success is humbling; response was unexpected: BasuMoneycontrol.com… Basu's latest film Barfi has charmed both filmgoers and critics alike. Combining modern outlook and cinematic aesthetics with a traditional Indian sensib…
Cell Therapeutics' phase 1 study of pacritinib shows encouraging anti-tumour … – pharmabiz.com
Cell Therapeutics' phase 1 study of pacritinib shows encouraging anti-tumour …pharmabiz.comPatients had relapsed following a median of five prior therapies (range 2-15); 44% had failed prior stem cell transplant and 52% were rituximab refractory….
Astellas seeks FDA approval for tacrolimus tablets – Pharmaceutical Business Review
Astellas seeks FDA approval for tacrolimus tabletsPharmaceutical Business ReviewAstellas Pharma US has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tacrolimus extended release capsules for the…
Bosses less likely to suffer heart attack: study – Business Standard
Bosses less likely to suffer heart attack: studyBusiness Standard… likely to suffer heart attack: study. Press Trust of India / London September 25, 2012, 16:15 … a new Harvard study has found. The study upheld the earlier research that showed bein…
Novartis Phase III study in acute heart failure – Pharmacy Europe
TopNews New ZealandNovartis Phase III study in acute heart failurePharmacy EuropePhase III study results show that investigational RLX030 (serelaxin) reduced all-cause mortality in patients with acute heart failure (AHF).[1] The six-month RELAX-AHF stu…
Astellas seeks US FDA approval for tacrolimus ER capsules – pharmabiz.com
Astellas seeks US FDA approval for tacrolimus ER capsulespharmabiz.comAstellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval fo…